ClinicalTrials.Veeva

Menu

The Effect of Prednisone on Physical Exercise in COPD Patients (COPDpred)

B

Bispebjerg Hospital

Status and phase

Completed
Phase 4

Conditions

Exercise Performance in Copd Patients

Treatments

Drug: prednisone

Study type

Interventional

Funder types

Other

Identifiers

NCT01978665
2012-004503-13 (EudraCT Number)

Details and patient eligibility

About

The objective of this study is to investigate if there is an effect on exercise performance og of the anti inflammatory drugs prednisone and solu-medrol in patints with chronic obstructive pulmonary disease(COPD)

Full description

RCT study with 4 days of steroid

Enrollment

14 patients

Sex

Male

Ages

40 to 75 years old

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:FEV1< 60% FEV1/FVC ratio <70 %

  • able to use a ergometer bike

Exclusion Criteria: Haemodynamicaly unstable heart conditions

  • exacerbations before 6 week entry of the study exacerbation during the study period treatment with beta blockers malignancy the last 5 years allergi toward IMP

Trial design

Primary purpose

Supportive Care

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

14 participants in 3 patient groups, including a placebo group

prednisone and Solumedrol
Placebo Comparator group
Description:
placebo arm versus prednisone
Treatment:
Drug: prednisone
solumedrol
Placebo Comparator group
Description:
placebo versus solu medrol
Treatment:
Drug: prednisone
placebo
Other group
Description:
measurement of fitness
Treatment:
Drug: prednisone

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems